Y Shi, M Wu, Y Liu, L Hu, H Wu, L Xie, Z Liu… - Frontiers in …, 2021 - frontiersin.org
Aims Anti-angiotherapy (Bevacizumab) is currently regarded as a promising option for
glioma patients who are resistant to temozolomide (TMZ) treatment. But ongoing clinical …